HARTLINE INVESTMENT CORP/ – SPDR S&P Biotech ETF Transaction History
HARTLINE INVESTMENT CORP/ portfolio value:
$0
portfolio value
HARTLINE INVESTMENT CORP/ quarter portfolio value change:
+6.80%
quarter
SPDR S&P Biotech ETF 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -15.91K shares | -2.24M | $79.32 | 0 |
| Q2 2022 | share | Increase | +8.72% | 1.27K shares | 259K | $74.27 | 15.91K |
| Q1 2022 | share | Increase | +168.41% | 9.18K shares | 1.37M | $89.88 | 14.63K |
| Q4 2021 | share | Decrease | -56.24% | -7.00K shares | -956K | $113.24 | 5.45K |
| Q3 2021 | share | Decrease | -14.86% | -2.17K shares | -415K | $125.71 | 12.46K |
| Q2 2021 | share | Decrease | -8.61% | -1.37K shares | -191K | $135.4 | 14.63K |
| Q1 2021 | share | Increase | +0.65% | 103 shares | -68K | $135.65 | 16.01K |
| Q4 2020 | share | Decrease | -12.83% | -2.34K shares | 207K | $140.74 | 15.91K |
| Q3 2020 | share | Decrease | -32.13% | -8.64K shares | -977K | $111.27 | 18.25K |
| Q2 2020 | share | Decrease | -46.12% | -23.02K shares | -855K | $111.7 | 26.9K |
| Q1 2020 | share | Decrease | -2.43% | -1.24K shares | -1.00M | $77.26 | 49.92K |
| Q4 2019 | share | Increase | +0.73% | 370 shares | 993K | $94.88 | 51.17K |
| Q3 2019 | share | Increase | +1.53% | 765 shares | -515K | $76.07 | 50.8K |
| Q2 2019 | share | Increase | +5.71% | 2.70K shares | 104K | $87.5 | 50.03K |
| Q1 2019 | share | Increase | +41.56% | 13.89K shares | 1.88M | $90.32 | 47.33K |
| Q4 2018 | share | Decrease | -12.54% | -4.79K shares | -1.26M | $71.58 | 33.43K |
| Q3 2018 | share | Increase | +26.05% | 7.90K shares | 778K | $95.62 | 38.22K |
| Q2 2018 | share | Increase | +0.55% | 165 shares | 241K | $94.87 | 30.32K |
| Q1 2018 | share | Decrease | -3.35% | -1.04K shares | -2K | $87.38 | 30.16K |
| Q4 2017 | share | Decrease | -66.18% | -61.07K shares | -5.34M | $84.48 | 31.20K |
| Q3 2017 | share | Increase | +1.17% | 1.07K shares | 949K | $86.14 | 92.28K |
| Q2 2017 | share | Decrease | -0.05% | -50 shares | 712K | $76.76 | 91.21K |
| Q1 2017 | share | Increase | +26.20% | 18.94K shares | 2.04M | $68.86 | 91.26K |
| Q4 2016 | share | Increase | +17.51% | 10.77K shares | 201K | $58.76 | 72.31K |
| Q3 2016 | share | Decrease | -2.19% | -1.37K shares | 677K | $65.79 | 61.53K |
| Q2 2016 | share | Increase | +337.45% | 48.53K shares | 2.65M | $53.65 | 62.91K |
| Q1 2016 | share | Decrease | -25.49% | -4.92K shares | -612K | $51.2 | 14.38K |